Tag: Erfo
Erfo, 2023 revenues at 6.2 million euros. EBITDA declining
(Finance) – Erfo Pharmaceutical Laboratorya company operating in the nutraceutical sector and listed on Euronext Growth Milan, closed on 2023 with revenues equal to 6.18 million euros, up 23% compared…
Erfo Pharmaceutical Laboratory, revenues for the first 9 months at 4.69 million
(Finance) – I revenues consolidated by the group Erfo Pharmaceutical Laboratory as of 30 September 2023 they amounted to approximately 4.69 million euros, up by 23% compared to 3.82 million…
Erfo, net profit down to 0.72 million in 2022
(Tiper Stock Exchange) – Erfo Pharmaceutical Laboratorya company operating in the nutraceutical sector and listed on Euronext Growth Milan, closed the 2022 with i revenues pro-forma equal to 6.04 million…
Erfo enters France and Belgium with the Dietnatural model
(Tiper Stock Exchange) – Erfo Pharmaceutical Laboratory (Erfo), Innovative SME and benefit company operating throughout the nutraceutical sector chain, ha signed today a binding agreement for the acquisition of 65%…
Erfo Pharmaceutical Laboratory lands on Euronext Growth Milan
(Finance) – Erfo Pharmaceutical Laboratory debuted today on Euronext Growth Milan. The company, an innovative SME operating in the nutraceutical sector, specializes in the formulation and production of food supplements,…
Erfo closes placement in the middle of the fork. 3.5 million euros raised
(Finance) – Erfoa Tuscan company operating in the nutraceutical sector, has successfully concluded the placement that will lead it, from 29 June 2022, to be listed on Euronext Growth Milan…